Twist Bioscience Corporation (TWST) – Significant growth in revenue leading the growth of the company

in , on February 17, 2021

NGS orders for the first quarter were $ 17mn, and that is growth of 44% year over year The primary reason for NGS tools revenue growth was the adoption of the product by a larger customer base and a $ 4.6mn shipment to a liquid biopsy customer.

Highlights 

Valuation

– Enterprise Value
– CrispIdea Forecast
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Segment Performance
– Key Developments

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership 

Stock Price Performance

CrispIdea Coverage 

No of Pages : 31

Release Information

  • Released
    :

    February 17, 2021

  • Last Updated
    :

    February 18, 2021